Highly expressed MRPL15 predicted poor outcomes in NSCLC; might be involved in modulating DNA replication, metabolism‐associated pathways, and cell cycle signaling; and was negatively related to immune infiltration [20]. This evidence concerns the gene MRPL15 and non-small cell lung carcinoma.